Xenikos B.V. Alternatives & Competitors
12 companies similar to Xenikos B.V. — Developing new, innovative immunotherapy medicines that reset the immune system
Companies similar to Xenikos B.V.
-logo.jpg "Enlivex Therapeutics (Nasdaq: ENLV)"){kind=logo}
Enlivex Therapeutics (Nasdaq: ENLV)
Immune rebalancing
Israel
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Taiga Biotechnologies
Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the...
Aurora, United States
Magenta Therapeutics
Developing novel medicines to bring the curative power of stem cell transplants to more pa...
Cambridge, United States
Track all Xenikos B.V. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
Revolo Biotherapeutics
Analyze | Reset | Revolutionize
Gaithersburg, United Stat...
Medeor Therapeutics, Inc.
Redefining Transplant
South San Francisco, Unit...
Walking Fish Therapeutics, Inc.
Engineering B Cell‐Based Protein Factories to Treat Serious Diseases.
South San Francisco, Unit...
SAB BIO
Working to transform treatment for people living with type 1 diabetes through a unique dis...
Miami, United States
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
Gaithersburg, United Stat...
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
About Xenikos B.V.
Xenikos B.V., founded in 2009 and headquartered in The Netherlands, is a clinical-stage biotechnology company noted for its slogan, "Developing new, innovative immunotherapy medicines that reset the immune system." The company is positioned at the intersection of biotechnology, health and wellness, and life sciences. I...
Development of Immunotherapy Medicines, Clinical Trials Management, Research on Immune System Disorders
Patients with Immune System Disorders, Healthcare Professionals in Transplant Medicine, Research Institutions
Immunotherapy, Clinical-stage, Graft-versus-host Disease, Steroid-refractory Conditions, Transplant Rejection, Antibody-based Therapy, Autoimmune Diseases, Solid-organ Rejection, Innovative Medicine Development, Immune System Reset, Drug Development, Clinical Development, Biopharmacy, Therapeutic Innovation
B2B, B2B2B, B2B2C
Product Sales, Licensing, Value Based Pricing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Xenikos B.V. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Xenikos B.V. on 11 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
